Please do not close or refresh this window...
Thursday, May 20, 2021 at 5:30 PM to 8:00 PM CDT
1628 21st Ave S, Nashville, TN, 37212, United States
Access code applied successfully. Remove
Invalid access code. Try again
E3 Chophouse, 1628 21st Ave S, Nashville, TN, 37212, United States.
Practical Considerations for Managing Adverse Events with Tukysa (tucatinib): A Treatment Option for Patients with HER-2+ Metastatic Breast Cancer (MBC)
Speaker:
Melissa Rikal, NP
Tennessee Oncology/Sarah Cannon Research Institute
Date:
Thursday, May 20th
Registration: 530 pm
Program Start: 6 pm
Location:
E3 Chophouse
1628 21st Ave South
Nashville, TN 37212
http://middletennessee.vc.ons.org
This event is currently unable to accept new registrations
Please enter below, the secure invite code provided to you by the event organizer in order to proceed...
(Please use a genuine email address. It will be used to validate your request)